Concepedia

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

Andrea Koch, Bengt Bergman, Erik Holmberg, Christer Sederholm, Lars Ek, Jaroslaw Kosieradzki, Kristina Lamberg, Lars Thaning, Sven-Olof Ydreborg, Sverre Sörenson

European Journal of Cancer · 2011 · 62 citations · 25 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyCancer Survival AnalysisLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Iii Clinical Trials

References

25

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

Pharmacy, Oncology, Cancer Symptom Management +15

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Estimates of the cancer incidence and mortality in Europe in 2006

Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology · 2007 · 4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +11

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

Stuart Pocock, Richard Simon · Biometrics · 1975 · 2.4K citations

Public Health, Biostatistics, Clinical Epidemiology +12

Estimates of cancer incidence and mortality in Europe in 2008

Jacques Ferlay, Donald Maxwell Parkin, Eva Steliarova‐Foucher · European Journal of Cancer · 2010 · 2.3K citations

Medicine, Health Sciences, Oncology +12